Sept 13 Biogen Inc and Eisai Co Ltd
are abandoning two late-stage trials for their
Alzheimer's treatment in a widely anticipated move that comes
months after the companies scrapped trials of another drug for
the memory-robbing disease.
Sept 12 Tocagen Inc's shares fell
nearly 80% after its experimental treatment failed to extend
life of brain cancer patients in a study, the latest in a series
of setbacks for patients awaiting new treatment options for the
Mallinckrodt Plc shares surged more than 50% on Tuesday after it agreed to sell its contract manufacturing unit to reduce debt and its chief executive officer raised hopes that the company could reach a global settlement to resolve all opioid litigation.
The U.S. patent office will review patents on Alexion Pharmaceuticals Inc's blood disorder treatment Soliris, after Amgen Inc challenged them, court filings showed on Friday.
Medtronic Plc beat analysts' estimates for quarterly profit on Tuesday, boosted by higher demand for its surgical instruments and diabetes devices, and the medical device maker raised its forecast for full-year adjusted profit as well.
Aug 16 Heart valve systems from Edwards
Lifesciences Corp and Medtronic Plc have been
approved for use in a condition that restricts blood flow from
the heart in patients at low-risk of death linked to open-heart
surgeries, the U.S. FDA said on Friday.
The U.S. Food and Drug Administration has approved TB Alliance's treatment for drug-resistant tuberculosis as part of a three-drug combination regimen called BPaL, the not-for-profit said on Wednesday.
An FDA advisory panel on Wednesday voted in favor of Gilead Sciences Inc's combination drug to reduce the risk of sexually acquired HIV infection in men and transgender women who have sex with men.
Centene Corp beat second-quarter sales targets and raised its 2019 earnings forecast on Tuesday, but the health insurer warned of higher medical costs from its Obamacare business this year.